Deciphering the mechanisms of action of progesterone in breast cancer

• Published in: Oncotarget 2023-07, Vol.14 (1), p.660-667
• Main Authors: Chakravorty, Gaurav, Ahmad, Suhail, Godbole, Mukul S, Gupta, Sudeep, Badwe, Rajendra A, Dutt, Amit
• Format: Article
• Language: English
• ISSN: 1949-2553; 1949-2553
• DOI: 10.18632/oncotarget.28455

A practice-changing, randomized, controlled clinical study established that preoperative hydroxyprogesterone administration improves disease-free and overall survival in patients with node-positive breast cancer. This research perspective summarizes evidences from our studies that preoperative hydroxyprogesterone administration may improve disease-free and overall survival in patients with node-positive breast cancer by modulating cellular stress response and negative regulation of inflammation. Non-coding RNAs, particularly , play a regulatory role in this process, along with the upregulation of the kinase gene and activation of the axis. Progesterone-induced modification of the progesterone receptor and estrogen receptor genomic binding pattern is also involved in orchestrating estrogen signaling in breast cancer, preventing cell migration and invasion, and improving patient outcomes. We also highlight the role of progesterone in endocrine therapy resistance, which could lead to novel treatment options for patients with hormone receptor-positive breast cancer and for those who develop resistance to traditional endocrine therapies.